Price
Target price
€33.40
€33.40
-0.600%
-0.2
-0.600%
€23.16
08.01.26 / Frankfurt
WKN: A1WZ6P / Symbol: PAHC / Name: Phibro Animl / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Phibro Animal Health Corp. A Stock
The price for the Phibro Animal Health Corp. A stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.600%).
Currently there is a rather positive sentiment for Phibro Animal Health Corp. A with 5 Buy predictions and 2 Sell predictions.
On the other hand, the target price of 23 € is below the current price of 33.4 € for Phibro Animal Health Corp. A, so the potential is actually -31.14%.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | -0.600% | 5.696% | 0.000% | 62.136% | 5.696% | 162.992% | 100.000% |
| Rockwell Medical Inc. | -0.960% | 13.833% | 4.222% | -59.381% | 22.247% | -21.981% | -91.258% |
| Pacira Pharmaceuticals | - | 7.767% | 4.717% | 25.424% | 2.778% | -34.706% | -60.357% |
| Twist Bioscience Corp | 3.320% | 9.837% | 11.778% | -30.567% | 9.048% | 32.187% | -77.832% |
Comments
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for PAHC provided by MarketBeat